Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phototherapy with or without clofibrate for jaundice in preterm neonates
IRCT20120215009014N343Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of clofibride in jaundice (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Mean reduction of total bilirubin. Started May 2019; status: completed.
02
Drugs
clofibride
03
Conditions
jaundice
Beyond the preview
Go deeper on IRCT20120215009014N343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N343.